Australia
· Delayed Price · Currency is AUD Algorae Pharmaceuticals Statistics
Total Valuation
ASX:1AI has a market cap or net worth of AUD 8.44 million. The enterprise value is 6.03 million.
| Market Cap | 8.44M |
| Enterprise Value | 6.03M |
Important Dates
The last earnings date was Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:1AI has 1.69 billion shares outstanding. The number of shares has increased by 10.68% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.69B |
| Shares Change (YoY) | +10.68% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 17.67% |
| Owned by Institutions (%) | 2.43% |
| Float | 1.05B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 67.39 |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.65 |
| EV / Sales | 48.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.41
| Current Ratio | 17.41 |
| Quick Ratio | 16.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.16% and return on invested capital (ROIC) is -15.41%.
| Return on Equity (ROE) | -43.16% |
| Return on Assets (ROA) | -14.71% |
| Return on Invested Capital (ROIC) | -15.41% |
| Return on Capital Employed (ROCE) | -31.00% |
| Revenue Per Employee | 2,608 |
| Profits Per Employee | -27,025 |
| Employee Count | 48 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.45, so ASX:1AI's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -40.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 43.55 |
| Average Volume (20 Days) | 846,888 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:1AI had revenue of AUD 125,200 and -1.30 million in losses. Loss per share was -0.00.
| Revenue | 125,200 |
| Gross Profit | 125,200 |
| Operating Income | -741,221 |
| Pretax Income | -1.30M |
| Net Income | -1.30M |
| EBITDA | n/a |
| EBIT | -741,221 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2.41 million in cash and n/a in debt, giving a net cash position of 2.41 million or 0.00 per share.
| Cash & Cash Equivalents | 2.41M |
| Total Debt | n/a |
| Net Cash | 2.41M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.39M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.39M |
Cash Flow
| Operating Cash Flow | -1.22M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -592.03% |
| Pretax Margin | -1,036.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:1AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.68% |
| Shareholder Yield | -10.68% |
| Earnings Yield | -15.38% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:1AI has an Altman Z-Score of 19.01.
| Altman Z-Score | 19.01 |
| Piotroski F-Score | n/a |